MarketPeel
Insider Trading Intelligence
Pricing
…
PL

Poplar Point Capital Management Llc

GYRO
INSIDER · GYRODYNE, LLC · CIK 0001588273
FILING MIX · LIFETIME95%/5%
BUYS
36
SELLS
2
TOTAL VALUE
$785.6K
COMPANIES
2
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
1,164,004
AVG SELL PX
$13.03
TRADE KIND
SHOWING 38 / 38
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
38 backtested trades · 8 horizons · 36 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Poplar Point Capital Management Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d38+23.68%-3.11%-1.38%-1.73%-2.31%-1.96
14d38+42.11%-3.62%-2.78%-0.84%-1.06%-0.68
30d38+15.79%-4.59%-3.33%-1.25%-0.14%-1.32
60d38+10.53%-6.31%+0.14%-6.45%-7.12%-5.98
90d38+26.32%-3.60%+4.82%-8.43%-9.42%-9.42
180d38+84.21%+179.32%+13.62%+165.71%+174.75%7.32
1y38+15.79%-26.96%+15.78%-42.73%-65.28%-3.98
2y38(36 pending)+100.00%-20.11%+2.09%-22.20%-22.20%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GYRO · 143,704 shares · as of Aug 30, 2021
037,47674,952112,428149,904SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 36 buys / 2 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
300$0.47$1401,020,300Apr 8, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
4,538$0.52$2.4K1,020,000Apr 4, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
22,976$0.56$12.9K1,015,462Apr 3, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
917$0.58$532992,486Apr 2, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
19,915$0.59$11.7K991,569Apr 1, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
21,654$0.59$12.8K971,654Mar 31, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
49,400$0.61$30.3K950,000Mar 28, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
18,504$0.62$11.4K900,000Mar 27, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
600$0.61$365900,600Mar 27, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
13,292$0.61$8.1K881,496Mar 26, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
22,635$0.61$13.8K868,204Mar 25, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
100$0.61$61845,569Mar 24, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
6,372$0.61$3.9K845,469Mar 21, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
5,320$0.61$3.3K839,097Mar 20, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
1,500$0.60$904833,777Mar 19, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
10,000$0.63$6.3K818,277Mar 18, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
14,000$0.63$8.8K832,277Mar 18, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
25,511$0.63$16.1K808,277Mar 14, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
34$0.64$22782,766Mar 13, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
11,837$0.62$7.4K782,732Mar 12, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
2,148$0.58$1.2K770,895Mar 11, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
14,645$0.58$8.5K768,747Mar 10, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
102$0.55$56754,102Mar 7, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
4,000$0.58$2.3K754,000Mar 4, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
13,108$0.60$7.9K750,000Feb 28, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
385$0.61$235736,892Feb 27, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
6,302$0.61$3.8K736,507Feb 26, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
25,033$0.62$15.5K730,205Feb 25, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
450$0.62$279705,172Feb 24, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
1,836$0.63$1.2K704,722Feb 20, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
49,664$0.67$33.3K702,886Feb 19, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
3,222$0.66$2.1K653,222Feb 18, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
26,718$0.64$17.0K650,000Feb 4, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
2,597$0.64$1.6K623,282Feb 3, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
70,685$0.65$45.8K620,685Jan 31, 2025Apr 14, 2025 ↗View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
31,703$0.69$21.9K550,000Jan 27, 2025Apr 14, 2025 ↗View →
GYRO
GYRODYNE, LLC
SALE
6,200$13.00$80.6K143,704Aug 30, 2021Aug 30, 2021 ↗View →
GYRO
GYRODYNE, LLC
SALE
30,000$13.04$391.2K149,904Aug 27, 2021Aug 30, 2021 ↗View →
Other insiders · GYRO
Loading peer insiders…
About this filer
CIK 0001588273
ROLE
Insider
PRIMARY
GYRO
COMPANIES
2
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001588273DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback